BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 29117210)

  • 1. Quality of life and impact of pain in women treated with aromatase inhibitors for breast cancer. A multicenter cohort study.
    Laroche F; Perrot S; Medkour T; Cottu PH; Pierga JY; Lotz JP; Beerblock K; Tournigand C; Chauvenet L; Bouhassira D; Coste J
    PLoS One; 2017; 12(11):e0187165. PubMed ID: 29117210
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Classification of and risk factors for estrogen deprivation pain syndromes related to aromatase inhibitor treatments in women with breast cancer: a prospective multicenter cohort study.
    Laroche F; Coste J; Medkour T; Cottu PH; Pierga JY; Lotz JP; Beerblock K; Tournigand C; Declèves X; de Cremoux P; Bouhassira D; Perrot S
    J Pain; 2014 Mar; 15(3):293-303. PubMed ID: 24365325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aromatase Inhibitors in Postmenopausal Women with Hormone Receptor-Positive Breast Cancer: Profiles of Psychological Symptoms and Quality of Life in Different Patient Clusters.
    Borreani C; Alfieri S; Infante G; Miceli R; Mariani P; Bosisio M; Vernieri C; Bianchi GV; Capri G
    Oncology; 2021; 99(2):84-95. PubMed ID: 32992318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of early therapy discontinuation and health-related quality of life in breast cancer patients treated with aromatase inhibitors: B-ABLE cohort study.
    Pineda-Moncusí M; Servitja S; Tusquets I; Diez-Perez A; Rial A; Cos ML; Campodarve I; Rodriguez-Morera J; Garcia-Giralt N; Nogués X
    Breast Cancer Res Treat; 2019 Aug; 177(1):53-60. PubMed ID: 31127467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adherence and quality of life in women with breast cancer being treated with oral hormone therapy.
    Stahlschmidt R; Ferracini AC; de Souza CM; de Medeiros LM; Juliato CRT; Mazzola PG
    Support Care Cancer; 2019 Oct; 27(10):3799-3804. PubMed ID: 30729297
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acupuncture for treatment of arthralgia secondary to aromatase inhibitor therapy in women with early breast cancer: pilot study.
    Oh B; Kimble B; Costa DS; Davis E; McLean A; Orme K; Beith J
    Acupunct Med; 2013 Sep; 31(3):264-71. PubMed ID: 23722951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single arm phase II study of oral vitamin B12 for the treatment of musculoskeletal symptoms associated with aromatase inhibitors in women with early stage breast cancer.
    Campbell A; Heydarian R; Ochoa C; Dwivedi AK; Nahleh ZA
    Breast J; 2018 May; 24(3):260-268. PubMed ID: 29442401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Musculoskeletal pain and health-related quality of life among breast cancer patients treated with aromatase inhibitors.
    Olufade T; Gallicchio L; MacDonald R; Helzlsouer KJ
    Support Care Cancer; 2015 Feb; 23(2):447-55. PubMed ID: 25128067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quality-of-life considerations in the treatment of early-stage breast cancer in the elderly.
    Reimer T; Gerber B
    Drugs Aging; 2010 Oct; 27(10):791-800. PubMed ID: 20883059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of joint symptoms in postmenopausal women taking aromatase inhibitors for early-stage breast cancer.
    Crew KD; Greenlee H; Capodice J; Raptis G; Brafman L; Fuentes D; Sierra A; Hershman DL
    J Clin Oncol; 2007 Sep; 25(25):3877-83. PubMed ID: 17761973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of aromatase inhibitors on sexual functioning: current knowledge and future research directions.
    Mok K; Juraskova I; Friedlander M
    Breast; 2008 Oct; 17(5):436-40. PubMed ID: 18479922
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bone health in a prospective cohort of postmenopausal women receiving aromatase inhibitors for early breast cancer.
    Servitja S; Nogués X; Prieto-Alhambra D; Martínez-García M; Garrigós L; Peña MJ; de Ramon M; Díez-Pérez A; Albanell J; Tusquets I
    Breast; 2012 Feb; 21(1):95-101. PubMed ID: 21924904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of quality of life in MA.17: a randomized, placebo-controlled trial of letrozole after 5 years of tamoxifen in postmenopausal women.
    Whelan TJ; Goss PE; Ingle JN; Pater JL; Tu D; Pritchard K; Liu S; Shepherd LE; Palmer M; Robert NJ; Martino S; Muss HB
    J Clin Oncol; 2005 Oct; 23(28):6931-40. PubMed ID: 16157934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Personality traits and psychosocial stress: quality of life over 2 years following breast cancer diagnosis and psychological impact factors.
    Härtl K; Engel J; Herschbach P; Reinecker H; Sommer H; Friese K
    Psychooncology; 2010 Feb; 19(2):160-9. PubMed ID: 19189279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of Adjuvant Endocrine Therapy on Quality of Life and Symptoms: Observational Data Over 12 Months From the Mind-Body Study.
    Ganz PA; Petersen L; Bower JE; Crespi CM
    J Clin Oncol; 2016 Mar; 34(8):816-24. PubMed ID: 26786934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of chemotherapy followed by aromatase inhibitors on bone health of women with ER-positive early breast cancer in real world clinical settings in Greece: Results of the POCHARBI trial conducted by the Hellenic Society of Breast Surgeons.
    Markopoulos C; Koukouras D; Venizelos V; Karyda I; Xepapadakis G; Misitzis J; Kalogerakos K; Poulakaki F; Natsiopoulos J; Zobolas V; Savidou C; Antonopoulou Z; Tzoracoleftherakis E
    Breast; 2016 Jun; 27():27-34. PubMed ID: 27212697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A qualitative exploration of the impact of yoga on breast cancer survivors with aromatase inhibitor-associated arthralgias.
    Galantino ML; Greene L; Archetto B; Baumgartner M; Hassall P; Murphy JK; Umstetter J; Desai K
    Explore (NY); 2012; 8(1):40-7. PubMed ID: 22225932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Health-related quality of life during adjuvant treatment for breast cancer among postmenopausal women.
    Browall M; Ahlberg K; Karlsson P; Danielson E; Persson LO; Gaston-Johansson F
    Eur J Oncol Nurs; 2008 Jul; 12(3):180-9. PubMed ID: 18343197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of lapatinib monotherapy on QOL and pain symptoms in patients with HER2+ relapsed or refractory inflammatory breast cancer.
    Kaufman B; Wu Y; Amonkar MM; Sherrill B; Bachelot T; Salazar V; Viens P; Johnston S
    Curr Med Res Opin; 2010 May; 26(5):1065-73. PubMed ID: 20214527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Health-related quality of life in early breast cancer.
    Groenvold M
    Dan Med Bull; 2010 Sep; 57(9):B4184. PubMed ID: 20816024
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.